The prevailing hypothesis is that the intended analgesic effects of opioid drugs are mediated by μ-opioid receptor signaling to G protein, while the side-effects of respiratory depression and analgesic tolerance are caused by engagement of the receptor with the arrestin-3 protein. The gene discussed is ARR3; the disease is Respiratory insufficiency due to muscle weakness.